Campbell & CO Investment Adviser LLC
Position in AMRX — Amneal Pharmaceuticals, Inc.
CIK 1353570
BALTIMORE, MD
Position in AMRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$753,506
+$663,757 QoQ
Shares Held
60,620
+114.8% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Campbell & CO Investment Adviser LLC holds $18,794,275 across 13 Drug Manufacturers - Specialty & Generic names. AMRX ranks #7 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
328,890 | $4,443,303 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
6,434 | $3,815,233 | |
| 3 | INDV |
Indivior Pharmaceuticals, Inc.
|
96,079 | $2,928,487 | |
| 4 | COLL |
Collegium Pharmaceutical, Inc
|
73,233 | $2,421,815 | |
| 5 | PAHC |
Phibro Animal Health Corp
|
27,606 | $1,526,887 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
54,422 | $756,465 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
This page
|
60,620 | $753,506 | |
| 8 | HLN |
Haleon plc
|
64,274 | $643,382 |
All Filings in AMRX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $753,506 | 60,620 | Shares | Sole | 2026-05-15 | |
| 2022-06-30 | $89,749 | 28,223 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $110,646 | 26,534 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $127,893 | 26,700 | Shares | Sole | 2022-02-10 | |
| No filing history on record for this holder in this stock. | ||||||